Carregant...
Miniatura

Tipus de document

Article

Versió

Versió publicada

Data de publicació

Llicència de publicació

cc-by (c)  Ortega, N. et al., 2021
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/225440

Seven-month kinetics of SARS-CoV-2 antibodies and protective role of pre-existing antibodies to seasonal human coronaviruses on COVID-19

Títol de la revista

Director/Tutor

ISSN de la revista

Títol del volum

Resum

Unraveling the long-term kinetics of antibodies to SARS-CoV-2 and the individual characteristics influencing it, including the impact of pre-existing antibodies to human coronaviruses causing common cold (HCoVs), is essential to understand protective immunity to COVID-19 and devise effective surveillance strategies. IgM, IgA and IgG levels against six SARS-CoV-2 antigens and the nucleocapsid antigen of the four HCoV (229E, NL63, OC43 and HKU1) were quantified by Luminex, and antibody neutralization capacity was assessed by flow cytometry, in a cohort of health care workers followed up to 7 months (N = 578). Seroprevalence increases over time from 13.5% (month 0) and 15.6% (month 1) to 16.4% (month 6). Levels of antibodies, including those with neutralizing capacity, are stable over time, except IgG to nucleocapsid antigen and IgM levels that wane. After the peak response, anti-spike antibody levels increase from ~150 days post-symptom onset in all individuals (73% for IgG), in the absence of any evidence of re-exposure. IgG and IgA to HCoV are significantly higher in asymptomatic than symptomatic seropositive individuals. Thus, pre-existing cross-reactive HCoVs antibodies could have a protective effect against SARS-CoV-2 infection and COVID-19 disease.

Citació

Citació

ORTEGA, Natalia, RIBES, Marta, VIDAL, Marta, RUBIO, Rocío, AGUILAR, Ruth, WILLIAMS, Sarah, BARRIOS, Diana, ALONSO, Selena, HERNÁNDEZ-LUIS, Pablo, MITCHELL, Robert a., JAIROCE, Chenjerai, CRUZ, Angeline, JIMÉNEZ, Alfons, SANTANO, Rebeca, MÉNDEZ, Susana, LAMOGLIA PUIG, Montserrat, ROSELL, Neus, LLUPIÀ GARCÍA, Anna, PUYOL, Laura, CHI, Jordi, RODRIGO-MELERO, Natalia, PARRAS, Daniel, SERRA, Pau, PRADENAS SAAVEDRA, Edwards, TRINITÉ, Benjamin, BLANCO, Julià, MAYOR APARICIO, Alfredo gabriel, BARROSO, Sonia, VARELA, Pilar, VILELLA, Anna, TRILLA GARCIA, Antonio de padua, SANTAMARIA, Pere, CAROLIS, Carlo, TORTAJADA, Marta, IZQUIERDO LÁZARO, Luis, ANGULO AGUADO, Ana, ENGEL, Pablo, GARCIA-BASTEIRO, Alberto l, MONCUNILL PIÑAS, Gemma, DOBAÑO, Carlota. Seven-month kinetics of SARS-CoV-2 antibodies and protective role of pre-existing antibodies to seasonal human coronaviruses on COVID-19. _Nature Communications_. 2021. Vol. 12, núm. 1. [consulta: 6 de febrer de 2026]. ISSN: 2041-1723. [Disponible a: https://hdl.handle.net/2445/225440]

Exportar metadades

JSON - METS

Compartir registre